person · Reporting owner

CHEW LEWIS

Disclosed activity across 5 companies

Tapewire entity: 10391
SEC CIK: 0001224994

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Arista Networks, Inc.ANET · Entity 2421	Director	August 20, 2026	August 24, 2026
CADENCE DESIGN SYSTEMS INCCDNS · Entity 2935	Director	May 07, 2026	May 11, 2026
Dolby Laboratories, Inc.DLB · Entity 2518	EVP & Chief Financial Officer	August 17, 2021	August 18, 2021
INTUITIVE SURGICAL INCISRG · Entity 2878	Director	April 30, 2026	May 01, 2026
PG&E CorpPCG · Entity 3143	Director	May 22, 2018	May 24, 2018

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Arista Networks, Inc.

Report date August 20, 2026 · Filed August 24, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	31,770	Reported balance After 2026-08-20 transaction · row 1 1 source row Row 1 · 2026-08-20 · Exercise / conversion · Acquired 538 · Balance 31,770 F1: Each restricted stock unit represents a contingent right to receive one share of Arista Networks, Inc. Common Stock upon vesting.
Restricted Stock Unit-6SEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	1,615	Reported balance After 2026-08-20 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-08-20 · Exercise / conversion · Disposed 538 · Balance 1,615 F1: Each restricted stock unit represents a contingent right to receive one share of Arista Networks, Inc. Common Stock upon vesting. F2: The reporting person was granted RSUs on May 29, 2026. 1/4th of the shares vest on August 20, 2026 and will continue to vest at the same rate on each quarterly vest date thereafter. A quarterly vest date is the first market trading day on or after February 20, May 20, August 20, or November 20.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents a contingent right to receive one share of Arista Networks, Inc. Common Stock upon vesting.

F2: The reporting person was granted RSUs on May 29, 2026. 1/4th of the shares vest on August 20, 2026 and will continue to vest at the same rate on each quarterly vest date thereafter. A quarterly vest date is the first market trading day on or after February 20, May 20, August 20, or November 20.

CADENCE DESIGN SYSTEMS INC

Report date May 07, 2026 · Filed May 11, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	9,131	Reported balance After 2026-05-07 transaction · row 1 1 source row Row 1 · 2026-05-07 · Grant · Acquired 714 · Balance 9,131 F1: Restricted stock award fully vests on the earlier to occur of (i) the first anniversary of the Grant Date and (ii) the date of the next Annual Meeting of Stockholders that follows the Grant Date.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock award fully vests on the earlier to occur of (i) the first anniversary of the Grant Date and (ii) the date of the next Annual Meeting of Stockholders that follows the Grant Date.

Dolby Laboratories, Inc.

Report date August 17, 2021 · Filed August 18, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	105,598	Last balance in matching sequence After 2021-08-17 transaction · row 5 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 5 source rows Row 1 · 2021-08-17 · Exercise / conversion · Acquired 30,000 · Balance 135,598 F1: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Row 2 · 2021-08-17 · Sale · Disposed 2,800 · Balance 132,798 F2: The shares were sold in multiple transactions at prices ranging from $101.37 to $102.35, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Row 3 · 2021-08-17 · Sale · Disposed 4,900 · Balance 127,898 F3: The shares were sold in multiple transactions at prices ranging from $100.36 to $101.29, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Row 4 · 2021-08-17 · Sale · Disposed 14,870 · Balance 113,028 F4: The shares were sold in multiple transactions at prices ranging from $99.31 to $100.29, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Row 5 · 2021-08-17 · Sale · Disposed 7,430 · Balance 105,598 F5: This transaction was executed in multiple trades at prices ranging from $99.15 to $99.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.15 · Expires 2022-12-15	Direct	10,625	Reported balance After 2021-08-17 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2021-08-17 · Exercise / conversion · Disposed 30,000 · Balance 10,625 F6: This performance-based stock option award was granted for a total of 32,500 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 125% of target, or 40,625 shares.

Filing footnotes · ownership attribution and instrument terms

F1: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest.

F2: The shares were sold in multiple transactions at prices ranging from $101.37 to $102.35, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F3: The shares were sold in multiple transactions at prices ranging from $100.36 to $101.29, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F4: The shares were sold in multiple transactions at prices ranging from $99.31 to $100.29, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F5: This transaction was executed in multiple trades at prices ranging from $99.15 to $99.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F6: This performance-based stock option award was granted for a total of 32,500 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 125% of target, or 40,625 shares.

INTUITIVE SURGICAL INC

Report date April 30, 2026 · Filed May 01, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,314	Reported balance After 2026-04-30 transaction · row 1 1 source row Row 1 · 2026-04-30 · Exercise / conversion · Acquired 531 · Balance 1,314
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2026-04-30 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-04-30 · Exercise / conversion · Disposed 531 · Balance 0 F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.
Restricted Stock Units - 4-30-2026SEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	554	Reported balance After 2026-04-30 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2026-04-30 · Grant · Acquired 554 · Balance 554 F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

Filing footnotes · ownership attribution and instrument terms

F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

PG&E Corp

Report date May 22, 2018 · Filed May 24, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	26,634.24	Reported balance After 2018-05-22 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2018-05-22 · Grant · Acquired 3,208 · Balance 26,634.24 F1: Restricted Stock Units (RSUs) granted under the PG&E Corporation 2014 Long Term Incentive Plan (LTIP). RSUs are payable in shares of PG&E Corporation common stock on a one-for-one basis. As described in the LTIP, RSUs vest upon the earliest of one year from the date of grant, the last day of the director's elected term, or a director's death, disability, or termination following a change in control. F2: This total reflects the acquisition of 27.44 RSUs on 7/17/17 and 34.42 RSUs on 10/16/17 pursuant to a dividend reinvestment feature of the LTIP.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted Stock Units (RSUs) granted under the PG&E Corporation 2014 Long Term Incentive Plan (LTIP). RSUs are payable in shares of PG&E Corporation common stock on a one-for-one basis. As described in the LTIP, RSUs vest upon the earliest of one year from the date of grant, the last day of the director's elected term, or a director's death, disability, or termination following a change in control.

F2: This total reflects the acquisition of 27.44 RSUs on 7/17/17 and 34.42 RSUs on 10/16/17 pursuant to a dividend reinvestment feature of the LTIP.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 20, 2022 Filed May 24, 2022 22:54 UTC	Arista Networks, Inc. ANET · Entity 2421	Exercise / conversionRestricted Stock Unit-1 · Derivative	616	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001596532-22-000144 · edgardoc.xml · derivative · entry 2 CHEW LEWIS · CIK 0001224994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 616 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Arista Networks, Inc. Common Stock upon vesting. F2 · derivative.exercise_date: The reporting person was granted RSUs on July 19, 2021. 1/4th of the shares vested on August 20, 2021 and will continue to vest at the same rate on each quarterly vest date thereafter. A quarterly vest date is the first market trading day on or after February 20, May 20, August 20, or November 20. F2 · derivative.expiration_date: The reporting person was granted RSUs on July 19, 2021. 1/4th of the shares vested on August 20, 2021 and will continue to vest at the same rate on each quarterly vest date thereafter. A quarterly vest date is the first market trading day on or after February 20, May 20, August 20, or November 20. Read SEC document
May 20, 2022 Filed May 24, 2022 22:54 UTC	Arista Networks, Inc. ANET · Entity 2421	Exercise / conversionCommon Stock	616	$0.00	$0.00	Disclosure SEC source: 0001596532-22-000144 · edgardoc.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Arista Networks, Inc. Common Stock upon vesting. Read SEC document
May 05, 2022 Filed May 9, 2022 22:42 UTC	CADENCE DESIGN SYSTEMS INC CDNS · Entity 2935	GrantCommon Stock	1,473	$0.00	$0.00	Disclosure SEC source: 0001209191-22-027934 · doc4.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,697 F1 · shares: Incentive stock award fully vests on the earlier to occur of (i) the first anniversary of the Grant Date and (ii) the date of the next Annual Meeting of Stockholders that follows the Grant Date. Read SEC document
February 22, 2022 Filed Feb 25, 2022 02:48 UTC	Arista Networks, Inc. ANET · Entity 2421	Exercise / conversionRestricted Stock Unit-1 · Derivative	612	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001596532-22-000058 · edgardoc.xml · derivative · entry 2 CHEW LEWIS · CIK 0001224994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 616 Underlying: Common Stock · 612 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Arista Networks, Inc. Common Stock upon vesting. F2 · derivative.exercise_date: The reporting person was granted RSUs on July 19, 2021. 1/4th of the shares vested on August 20, 2021 and will continue to vest at the same rate on each quarterly vest date thereafter. A quarterly vest date is the first market trading day on or after February 20, May 20, August 20, or November 20. F2 · derivative.expiration_date: The reporting person was granted RSUs on July 19, 2021. 1/4th of the shares vested on August 20, 2021 and will continue to vest at the same rate on each quarterly vest date thereafter. A quarterly vest date is the first market trading day on or after February 20, May 20, August 20, or November 20. Read SEC document
February 22, 2022 Filed Feb 25, 2022 02:48 UTC	Arista Networks, Inc. ANET · Entity 2421	Exercise / conversionCommon Stock	612	$0.00	$0.00	Disclosure SEC source: 0001596532-22-000058 · edgardoc.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Arista Networks, Inc. Common Stock upon vesting. Read SEC document
November 22, 2021 Filed Nov 24, 2021 23:49 UTC	Arista Networks, Inc. ANET · Entity 2421	Exercise / conversionRestricted Stock Unit-1 · Derivative	616	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001596532-21-000403 · edgardoc.xml · derivative · entry 2 CHEW LEWIS · CIK 0001224994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,228 Underlying: Common Stock · 616 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Arista Networks, Inc. Common Stock upon vesting. F3 · derivative.exercise_date: The reporting person was granted RSUs on July 19, 2021. 1/4th of the shares vested on August 20, 2021 and will continue to vest at the same rate on each quarterly vest date thereafter. A quarterly vest date is the first market trading day on or after February 20, May 20, August 20, or November 20. F3 · derivative.expiration_date: The reporting person was granted RSUs on July 19, 2021. 1/4th of the shares vested on August 20, 2021 and will continue to vest at the same rate on each quarterly vest date thereafter. A quarterly vest date is the first market trading day on or after February 20, May 20, August 20, or November 20. Read SEC document
November 22, 2021 Filed Nov 24, 2021 23:49 UTC	Arista Networks, Inc. ANET · Entity 2421	Exercise / conversionCommon Stock	616	$0.00	$0.00	Disclosure SEC source: 0001596532-21-000403 · edgardoc.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,232 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Arista Networks, Inc. Common Stock upon vesting. F2 · balance_after: On November 18, 2021, the issuer completed a four-for-one stock split of the issuer's common stock. All amounts have been adjusted to give effect to this stock split. Read SEC document
August 20, 2021 Filed Aug 25, 2021 01:31 UTC	Arista Networks, Inc. ANET · Entity 2421	Exercise / conversionRestricted Stock Unit-1 · Derivative	154	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001596532-21-000290 · edgardoc.xml · derivative · entry 2 CHEW LEWIS · CIK 0001224994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 461 Underlying: Common Stock · 154 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The reporting person was granted 615 RSUs on July 19, 2021. 1/4th of the shares vest on August 20, 2021 and will continue to vest at the same rate on each quarterly vest date thereafter. A quarterly vest date is the first market trading day on or after February 20, May 20, August 20, or November 20. F2 · derivative.expiration_date: The reporting person was granted 615 RSUs on July 19, 2021. 1/4th of the shares vest on August 20, 2021 and will continue to vest at the same rate on each quarterly vest date thereafter. A quarterly vest date is the first market trading day on or after February 20, May 20, August 20, or November 20. Read SEC document
August 20, 2021 Filed Aug 25, 2021 01:31 UTC	Arista Networks, Inc. ANET · Entity 2421	Exercise / conversionCommon Stock	154	$0.00	$0.00	Disclosure SEC source: 0001596532-21-000290 · edgardoc.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Arista Networks, Inc. Common Stock upon vesting. Read SEC document
August 17, 2021 Filed Aug 18, 2021 22:21 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	30,000	$0.00 Strike: $33.15	$0.00	Disclosure SEC source: 0001209191-21-052345 · doc4.xml · derivative · entry 6 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,625 Underlying: Class A Common Stock · 30,000 shares Expires 2022-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This performance-based stock option award was granted for a total of 32,500 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 125% of target, or 40,625 shares. Read SEC document
August 17, 2021 Filed Aug 18, 2021 22:21 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	SaleClass A Common Stock	7,430	$99.20	$737,030.00	Disclosure SEC source: 0001209191-21-052345 · doc4.xml · nonDerivative · entry 5 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,598 F5 · price: This transaction was executed in multiple trades at prices ranging from $99.15 to $99.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
August 17, 2021 Filed Aug 18, 2021 22:21 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	SaleClass A Common Stock	14,870	$99.65	$1,481,770.22	Disclosure SEC source: 0001209191-21-052345 · doc4.xml · nonDerivative · entry 4 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,028 F4 · price: The shares were sold in multiple transactions at prices ranging from $99.31 to $100.29, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
August 17, 2021 Filed Aug 18, 2021 22:21 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	SaleClass A Common Stock	4,900	$100.82	$494,037.60	Disclosure SEC source: 0001209191-21-052345 · doc4.xml · nonDerivative · entry 3 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,898 F3 · price: The shares were sold in multiple transactions at prices ranging from $100.36 to $101.29, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
August 17, 2021 Filed Aug 18, 2021 22:21 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	SaleClass A Common Stock	2,800	$101.68	$284,691.12	Disclosure SEC source: 0001209191-21-052345 · doc4.xml · nonDerivative · entry 2 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,798 F2 · price: The shares were sold in multiple transactions at prices ranging from $101.37 to $102.35, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
August 17, 2021 Filed Aug 18, 2021 22:21 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Exercise / conversionClass A Common Stock	30,000	$33.15	$994,500.00	Disclosure SEC source: 0001209191-21-052345 · doc4.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
August 06, 2021 Filed Aug 9, 2021 21:12 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	15,000	$0.00 Strike: $33.15	$0.00	Disclosure SEC source: 0001209191-21-050422 · doc4.xml · derivative · entry 8 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 15,000 shares Expires 2025-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option was granted for a total of 65,000 shares of Class A Common. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2015, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document
August 06, 2021 Filed Aug 9, 2021 21:12 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	SaleClass A Common Stock	2,400	$98.87	$237,277.92	Disclosure SEC source: 0001209191-21-050422 · doc4.xml · nonDerivative · entry 6 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,598 F5 · price: The shares were sold in multiple transactions at prices ranging from $98.74 to $99.07, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
August 06, 2021 Filed Aug 9, 2021 21:12 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	SaleClass A Common Stock	12,600	$98.26	$1,238,081.04	Disclosure SEC source: 0001209191-21-050422 · doc4.xml · nonDerivative · entry 5 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,998 F4 · price: The shares were sold in multiple transactions at prices ranging from $97.74 to $98.73, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
August 06, 2021 Filed Aug 9, 2021 21:12 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Exercise / conversionClass A Common Stock	15,000	$33.15	$497,250.00	Disclosure SEC source: 0001209191-21-050422 · doc4.xml · nonDerivative · entry 4 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
August 05, 2021 Filed Aug 9, 2021 21:12 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	30,000	$0.00 Strike: $33.15	$0.00	Disclosure SEC source: 0001209191-21-050422 · doc4.xml · derivative · entry 7 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 30,000 shares Expires 2025-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option was granted for a total of 65,000 shares of Class A Common. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2015, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document
August 05, 2021 Filed Aug 9, 2021 21:12 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	SaleClass A Common Stock	9,302	$97.86	$910,302.09	Disclosure SEC source: 0001209191-21-050422 · doc4.xml · nonDerivative · entry 3 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,598 F3 · price: The shares were sold in multiple transactions at prices ranging from $97.75 to $97.95, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
August 05, 2021 Filed Aug 9, 2021 21:12 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	SaleClass A Common Stock	20,698	$97.38	$2,015,672.66	Disclosure SEC source: 0001209191-21-050422 · doc4.xml · nonDerivative · entry 2 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,900 F2 · price: The shares were sold in multiple transactions at prices ranging from $96.74 to $97.73, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
August 05, 2021 Filed Aug 9, 2021 21:12 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Exercise / conversionClass A Common Stock	30,000	$33.15	$994,500.00	Disclosure SEC source: 0001209191-21-050422 · doc4.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
August 04, 2021 Filed Aug 5, 2021 22:16 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	20,000	$0.00 Strike: $33.15	$0.00	Disclosure SEC source: 0001209191-21-050041 · doc4.xml · derivative · entry 9 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Class A Common Stock · 20,000 shares Expires 2025-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option was granted for a total of 65,000 shares of Class A Common. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2015, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document
August 04, 2021 Filed Aug 5, 2021 22:16 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	10,000	$0.00 Strike: $42.98	$0.00	Disclosure SEC source: 0001209191-21-050041 · doc4.xml · derivative · entry 8 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 10,000 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 97,918 shares of Class A Common. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2014, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document
August 04, 2021 Filed Aug 5, 2021 22:16 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	SaleClass A Common Stock	20,000	$97.29	$1,945,882.00	Disclosure SEC source: 0001209191-21-050041 · doc4.xml · nonDerivative · entry 6 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,598 F4 · price: The shares were sold in multiple transactions at prices ranging from $96.96 to $97.62, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
August 04, 2021 Filed Aug 5, 2021 22:16 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Exercise / conversionClass A Common Stock	20,000	$33.15	$663,000.00	Disclosure SEC source: 0001209191-21-050041 · doc4.xml · nonDerivative · entry 5 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
August 04, 2021 Filed Aug 5, 2021 22:16 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	SaleClass A Common Stock	10,000	$97.99	$979,893.00	Disclosure SEC source: 0001209191-21-050041 · doc4.xml · nonDerivative · entry 4 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,598 F3 · price: The shares were sold in multiple transactions at prices ranging from $97.62 to $98.95, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
August 04, 2021 Filed Aug 5, 2021 22:16 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Exercise / conversionClass A Common Stock	10,000	$42.98	$429,800.00	Disclosure SEC source: 0001209191-21-050041 · doc4.xml · nonDerivative · entry 3 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
August 03, 2021 Filed Aug 5, 2021 22:16 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	20,000	$0.00 Strike: $42.98	$0.00	Disclosure SEC source: 0001209191-21-050041 · doc4.xml · derivative · entry 7 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Class A Common Stock · 20,000 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 97,918 shares of Class A Common. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2014, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document
August 03, 2021 Filed Aug 5, 2021 22:16 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	SaleClass A Common Stock	20,000	$99.54	$1,990,712.00	Disclosure SEC source: 0001209191-21-050041 · doc4.xml · nonDerivative · entry 2 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,598 F2 · price: This transaction was executed in multiple trades at prices ranging from $99.23 to $99.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
August 03, 2021 Filed Aug 5, 2021 22:16 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Exercise / conversionClass A Common Stock	20,000	$42.98	$859,600.00	Disclosure SEC source: 0001209191-21-050041 · doc4.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
July 19, 2021 Filed Jul 21, 2021 23:36 UTC	Arista Networks, Inc. ANET · Entity 2421	GrantRestricted Stock Unit-1 · Derivative	615	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001596532-21-000248 · edgardoc.xml · derivative · entry 1 CHEW LEWIS · CIK 0001224994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 615 Underlying: Common Stock · 615 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Arista Networks, Inc. Common Stock upon vesting. F2 · derivative.exercise_date: The reporting person was granted 615 RSUs on July 19, 2021. 1/4th of the shares vest on August 20, 2021 and will continue to vest at the same rate on each quarterly vest date thereafter. A quarterly vest date is the first market trading day on or after February 20, May 20, August 20, or November 20. F2 · derivative.expiration_date: The reporting person was granted 615 RSUs on July 19, 2021. 1/4th of the shares vest on August 20, 2021 and will continue to vest at the same rate on each quarterly vest date thereafter. A quarterly vest date is the first market trading day on or after February 20, May 20, August 20, or November 20. Read SEC document
May 20, 2021 Filed May 21, 2021 01:07 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	30,918	$0.00 Strike: $42.98	$0.00	Disclosure SEC source: 0001209191-21-034731 · doc4.xml · derivative · entry 3 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Class A Common Stock · 30,918 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 97,918 shares of Class A Common. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2014, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document
May 20, 2021 Filed May 21, 2021 01:07 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	SaleClass A Common Stock	30,918	$96.67	$2,988,957.46	Disclosure SEC source: 0001209191-21-034731 · doc4.xml · nonDerivative · entry 2 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,598 F2 · price: This transaction was executed in multiple trades at prices ranging from $96.19 to $96.915. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
May 20, 2021 Filed May 21, 2021 01:07 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Exercise / conversionClass A Common Stock	30,918	$42.98	$1,328,855.64	Disclosure SEC source: 0001209191-21-034731 · doc4.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
February 25, 2021 Filed Mar 2, 2021 02:24 UTC	CADENCE DESIGN SYSTEMS INC CDNS · Entity 2935	GrantCommon Stock	1,377	$0.00	$0.00	Disclosure SEC source: 0001209191-21-015537 · doc4.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,224 F1 · shares: Incentive stock award fully vests on February 25, 2022. Read SEC document
February 02, 2021 Filed Feb 4, 2021 23:41 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	30,000	$0.00 Strike: $42.98	$0.00	Disclosure SEC source: 0001209191-21-007874 · doc4.xml · derivative · entry 3 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,918 Underlying: Class A Common Stock · 30,000 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 97,918 shares of Class A Common. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2014, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document
February 02, 2021 Filed Feb 4, 2021 23:41 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	SaleClass A Common Stock	30,000	$90.82	$2,724,669.00	Disclosure SEC source: 0001209191-21-007874 · doc4.xml · nonDerivative · entry 2 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,598 F2 · price: This transaction was executed in multiple trades at prices ranging from $90.31 to $91.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
February 02, 2021 Filed Feb 4, 2021 23:41 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Exercise / conversionClass A Common Stock	30,000	$42.98	$1,289,400.00	Disclosure SEC source: 0001209191-21-007874 · doc4.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
December 17, 2020 Filed Dec 21, 2020 22:49 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Tax withholdingClass A Common Stock	1,612	$91.03	$146,740.36	Disclosure SEC source: 0001209191-20-064691 · doc4.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,598 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 34,172 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document
December 16, 2020 Filed Dec 18, 2020 00:24 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Tax withholdingClass A Common Stock	1,637	$92.08	$150,734.96	Disclosure SEC source: 0001209191-20-064230 · doc4.xml · nonDerivative · entry 3 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,210 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F5 · balance_after: Shares held following the reported transactions include 37,422 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document
December 15, 2020 Filed Dec 18, 2020 00:24 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	GrantEmployee Stock Option (Right to Buy) · Derivative	30,553	$0.00 Strike: $92.08	$0.00	Disclosure SEC source: 0001209191-20-064230 · doc4.xml · derivative · entry 5 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,553 Underlying: Class A Common Stock · 30,553 shares Expires 2030-12-15 F7 · derivative.exercise_date: This option was granted for a total of 30,553 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2020, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document
December 15, 2020 Filed Dec 18, 2020 00:24 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	GrantPerformance-Based Restricted Stock Unit · Derivative	7,136	$0.00	$0.00	Disclosure SEC source: 0001209191-20-064230 · doc4.xml · derivative · entry 4 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,136 Underlying: Class A Common Stock · 7,136 shares Expires not disclosed F6 · derivative.exercise_price: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F6 · derivative.exercise_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F6 · derivative.expiration_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document
December 15, 2020 Filed Dec 18, 2020 00:24 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	GrantClass A Common Stock	14,272	$0.00	$0.00	Disclosure SEC source: 0001209191-20-064230 · doc4.xml · nonDerivative · entry 2 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,847 F3 · acquired: Award represents a total of 14,272 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2020. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F4 · balance_after: Shares held following the reported transactions include 40,722 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document
December 15, 2020 Filed Dec 18, 2020 00:24 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Tax withholdingClass A Common Stock	3,472	$90.86	$315,465.92	Disclosure SEC source: 0001209191-20-064230 · doc4.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,575 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 26,450 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document
November 17, 2020 Filed Nov 19, 2020 01:22 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	7,000	$0.00 Strike: $42.98	$0.00	Disclosure SEC source: 0001209191-20-059282 · doc4.xml · derivative · entry 6 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,918 Underlying: Class A Common Stock · 7,000 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 97,918 shares of Class A Common. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2014, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document
November 17, 2020 Filed Nov 19, 2020 01:22 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	23,652	$0.00 Strike: $37.35	$0.00	Disclosure SEC source: 0001209191-20-059282 · doc4.xml · derivative · entry 5 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 23,652 shares Expires 2023-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted for a total of 103,652 shares of Class A Common. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 16, 2013, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document
November 17, 2020 Filed Nov 19, 2020 01:22 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	SaleClass A Common Stock	7,000	$89.11	$623,766.50	Disclosure SEC source: 0001209191-20-059282 · doc4.xml · nonDerivative · entry 4 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,047 F3 · price: This transaction was executed in multiple trades at prices ranging from $88.93 to $89.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 33,450 restricted stock units, which are subject to forfeiture until they vest. Read SEC document
November 17, 2020 Filed Nov 19, 2020 01:22 UTC	Dolby Laboratories, Inc. DLB · Entity 2518	Exercise / conversionClass A Common Stock	7,000	$42.98	$300,860.00	Disclosure SEC source: 0001209191-20-059282 · doc4.xml · nonDerivative · entry 3 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,450 restricted stock units, which are subject to forfeiture until they vest. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.